CYBERDYNE : 【News】Insurance coverage approved for the treatment of HAM and Hereditary Spastic Paraplegia using Medical HAL -October 05, 2023 at 05:11 am EDT

CYBERDYNE Inc. announced today that its application for public insurance coverage for the treatment of HTLV-1 Associated Myelopathy and Hereditary Spastic Paraplegia was approved by the...

Related Keywords

Japan ,Niigata ,Tokushima ,Fukuoka ,Kyoto ,Kirishima ,Japan General ,Ibaraki ,Osaka ,Tsukuba ,Takashi Nakajima ,Yoshiyuki Sankai ,Gait Movement Procedure ,National Hospital Organization Murayama Medical Center ,National Hospital Organization Niigata Principal Investigator ,Practical Application Research Project For Intractable Diseases ,Ministry Of Health ,Fukuoka University Hospital ,National Hospital Organization Tokushima ,Scientific Research ,Kirishima Rehabilitation Center ,Kyoto Prefectural University Of Medicine Hospital ,National Hospital Organization Niigata ,Marianna University Hospital ,University Of Tsukuba Hospital ,Japan Agency For Medical Research ,Kagoshima University Hospital ,Hereditary Spastic Paraplegia ,Appropriate Use ,Movement Procedure ,Robot Suit ,Limb Type ,Application Research Project ,Initiated Clinical Study ,Wearable Assistive Robot ,Lower Limbs Controlled Voluntarily ,Bioelectric Signals ,Hybrid Assistive Limb ,New Medical Device ,Delay Progression ,Intractable Rare Neuromuscular ,Principal Investigator ,Japan Agency ,Medical Research ,Kyoto Prefectural University ,Medicine Hospital ,Tsukuba Hospital ,National Hospital Organization Murayama Medical ,Markets ,